SynthesisHypertension research : official journal of the Japanese Society of Hypertension2025
Prevalence and management of hypertension in childhood, adolescent, and young adult cancer survivors: a systematic review and meta-analysis.
Synthesis in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent updates and perspectives in "Onco-hypertension".Hypertension research : official journal of the Japanese Society of Hypertension · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improvements in cancer survival rates have drawn attention to the long-term cardiovascular health of childhood and adolescent/young adult (AYA) cancer survivors. Hypertension is a key modifiable risk factor contributing to elevated cardiovascular morbidity and mortality in this population. However, its prevalence and persistence remain underexplored. To address this gap, we conducted a systematic review and meta-analysis by searching the PubMed, EMBASE, Cochrane, and Web of Science databases for studies on childhood and AYA cancer survivors who had completed treatment. Hypertension prevalence was pooled using a random-effects model, with subgroup analyses conducted by cancer types and follow-up duration. Meta-regression analysis assessed trends in hypertension prevalence over time. A total of 91 studies involving 86,132 patients met the inclusion criteria. The pooled prevalence of hypertension was 20.35% (95% CI, 17.90-22.80). Subgroup analysis demonstrated a significant time-dependent increase in hypertension prevalence: 16.60% within 10 years, 17.48% at 10-20 years, and 32.12% after 20 years (P = 0.04). Survivors of kidney tumors (24.80%) exhibited a trend toward higher hypertension prevalence compared to other cancer types. Meta-regression analysis confirmed that hypertension prevalence started increasing in the early post-treatment phase and remained significantly elevated over time, emphasizing the progressive and sustained cardiovascular risk in this population. Childhood and AYA cancer survivors face substantial and persistent risks of hypertension, underscoring the need for early detection and long-term management strategies. Enhanced survivorship care tailored to this population is essential to reduce cardiovascular risks and improve life expectancy globally.
Indexed as
Identifiers
40629139What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.